FDA Remarks On CBD Should Restart Suit, Consumers Say
A proposed class of consumers whose action against CBD company CV Sciences has been paused told a California federal judge that recent comments from the U.S. Food and Drug Administration regarding...To view the full article, register now.
Already a subscriber? Click here to view full article